Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment

• Published in: International journal for parasitology -- drugs and drug resistance Vol. 11; pp. 95 - 100
• Main Authors: Burgaña, Ander, Abellana, Rosa, Yordanov, Stanislav Zlatanov, Kazan, Rabee, Pérez Ortiz, A. Mauricio, Ramos, Cristina Castillo, Hernández, Christian Garavito, Rivero, Miriam Molina, Gonçalves, Alessandra Queiroga, Padilla, Emma, Pérez, Josefa, García-Puig, Roger, Perez-Porcuna, Tomas M
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Ltd 01.12.2019; Elsevier
• Subjects: Adolescent; Adult; Antiprotozoal Agents - therapeutic use; Child; Clinical efficacy; Dientamoeba - drug effects; Dientamoeba fragilis; Dientamoebiasis - drug therapy; Feces - parasitology; Female; Humans; Longitudinal Studies; Male; Metronidazole; Metronidazole - therapeutic use; Middle Aged; Parasites; Paromomycin; Paromomycin - therapeutic use; Regular; Spain; Therapy; Treatment Outcome; Young Adult; Spain; Therapy; Dientamoeba fragilis; Metronidazole; Parasites; Paromomycin; Clinical efficacy

Dientamoeba fragilis is a trichomonad parasite of the human intestine that is found worldwide. However, the biological cycle and transmission of this parasite have yet to be elucidated. Although its pathogenic capacity has been questioned, there is increasing evidence that clinical manifestations va...